Teva, Intel to develop wearables to monitor Huntington's disease

(Reuters) - Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable device to monitor patients with Huntington's, a fatal degenerative disease.

from Reuters: Technology News http://ift.tt/2cQxug1